Zenome is a decentralized market of genomic data and services. They buy your data. You buy their services. Bitcoin is a digital money. Zenome is a digital you.
The Zenome project is a decentralized blockchain-driven database of genomic information. This platform supports the possibility to manage your genomic data while maintaining privacy and ability to make a profit from selling access to different parts of the genome. It will establish equal conditions for drug development and for the progress of scientic and medical technologies.
Development of MVP - IT - DEC 2017
Development of web-interface capable of uploading genetic data to the network and providing personalized genetic report. The first service provider on the Zenome platform.
Pilot - MAR 2018
The establishment of a network for distributed storing of genetic information. Development of a client application capable of uploading genetic data from user's PC.
B-version - MAY 2018
Using smart-contacts to enforce operations with genetic data: buying, selling, transferring.
Fund Zenome - JUN 2018
The establishment of Zenome Fund to support projects based on a platform. The Main Committee of Zenome Fund would be established.
Lab partnership - SEP 2018
The establishment of a broad network of partnerships with genetic labs. Collecting genetic material and adding these DNA samples to the network. Achieve the size of 2 000 000 active users.
Creation of the Market - DEC 2018
Commercialization. The start of the active genetic data exchange between the users.
Big Pharma partnership - MAR 2019
Reach a partnership agreement with Big Pharma. Start developing personalized drugs based on the genetic data collected.
FMCG partnership - AUG 2019
Reach a partnership agreement with leading FMCG-companies. Start developing personalized nutrition based on the genetic data collected.